布普伦诺芬诱导人类胎儿膜无菌炎症
Tatyana Lynn1, Megan E Kelleher1, Hanah M Georges1
1Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT, United States.
Journal of reproductive immunology
|February 6, 2025
概括
用于治疗怀孕期间阿片类药物使用障碍的布普伦诺芬,显著增加人类胎儿膜的炎症和削弱因素. 这可能解释了怀孕期间与阿片类药物治疗相关的早产风险增加.
科学领域:
- 生殖生物学 生殖生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 怀孕期间的阿片类药物使用障碍 (OUD) 是一个越来越令人担忧的问题,与母亲的死亡率和早产有关.
- 虽然建议使用布普伦诺芬等药物治疗OUD,但在接受治疗的个体中,早产率仍然很高.
研究的目的:
- 调查布普伦诺芬是否会诱导人类胎儿膜 (FM) 的无菌炎症.
- 探索布普伦诺芬诱导的炎症和潜在的胎儿膜衰弱的潜在机制.
主要方法:
- 利用一个体外人类 FM 探索系统来研究布普伦诺芬的作用.
- 测量了炎症性细胞因子 (IL-6,IL-8,IL-1β),前列腺素E2 (PGE2) 和矩阵金属蛋白酶 (MMP1,MMP9) 的分泌.
- 研究了托尔类受体4 (TLR4),NLRP3炎症体,μ-阿片类受体和下游信号通路 (NFκB,ERK/JNK/MAPK) 的作用.
主要成果:
- 布普伦诺芬显著增加了IL-6,IL-8和IL-1β的FM分泌.
- 在暴露于布普伦诺芬的FM中观察到高水平的PGE2,MMP1和MMP9.
- 炎症反应部分是由TLR4,NLRP3炎症酶,μ-阿片类受体和NFκB/ERK/JNK/MAPK信号传递的介导.
结论:
- 布普伦诺芬会诱导人类胎儿膜的无菌炎症和削弱.
- 这些发现表明,一种潜在的机制将怀孕期间的布普伦诺芬治疗与早产风险增加联系起来.
相关概念视频
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
211
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
211
01:25Analgesia and Pain Management
443
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
443